Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis

EMBO Journal

Volumn 15, Issue 14, 1996, Pages 3693-3701

  Attardi, Laura Donatella ^b   Lowe, Scott W ^c   Brugarolas, James ^b   Jacks, Tyler ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Watson School of Biological Sciences   (United States)

Author keywords

Apoptosis; G1 arrest; p21; p53; Transcriptional transactivation

Indexed keywords

ETOPOSIDE; ONCOPROTEIN; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; MICROINJECTION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0030013337     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00739.x     Document Type: Article

References (43)

1. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T. and Hannon, G. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377, 552-557.
2. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
3. Canman, C.E., Gilmer, T.M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
4. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
5. Debbas, M. and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7, 546-554.
6. CIPI/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684.
7. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
8. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J. and Reed, S.I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
9. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
10. Fisher, D. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542.
11. Friend, S. (1994) p53: a glimpse at the puppet behind the shadow play. Science, 265, 334-335.
12. Guillouf, C., Grana, X., Selvakumaran, M., De Luca, A., Giordano, A., Hoffman, B. and Liebermann, D.A. (1995) Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood, 85, 2691-2698.
13. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
14. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 Cdk-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
15. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9, 2170-2183.
16. Hollstein, M., Sidranksy, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
17. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
18. Kastan, M., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J., Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is detective in ataxia-telangiectasia. Cell, 71, 587-597.
19. Knudson, C.M., Tung, K.S.K., Tourtellotte, W.G., Brown, G.A.J. and Korsmeyer, S.J. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science, 270, 96-99.
20. Levine, A.J. (1993) The tumor suppressor genes. Annu. Rev. Biochem., 62, 623-651.
21. Lin, J., Chen, J., Elenbaas, B. and Levine, A.J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2, and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8, 1235-1246.
22. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
23. Lowe, S.W. (1995) Cancer therapy and p53. Curr. Opin. Oncol., 7, 547-553.
24. Lowe, S.W. and Ruley, H.E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes Dev., 7, 535-545.
25. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53-dependent apoptosis modulates the cytoxicity of anticancer agents. Cell, 74, 957-967.
26. Lowe, S.W., Bodis, S., McClatchey, A., Remington, L., Ruley, H.E., Fisher, D.E., Housman, D.E. and Jacks, T. (1994a) p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
27. Lowe, S.W., Jacks, T., Housman, D.E. and Ruley, H.E. (1994b) Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl Acad. Sci. USA, 91, 2026-2030.
28. Malkin, D. (1993) p53 and the Li-Fraumeni syndrome. Cancer Genet. Cytogenet., 66, 83-92.
29. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
30. Oliner, J.D. (1993) Discerning the function of p53 by examining its molecular interactions. BioEssays, 15, 703-707.
31. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerate programmed cell death. Cell, 74, 609-619.
32. Pietenpol, J.A., Tokino, T., Thiagalingam, S., El-Deiry, W., Kinzler, K.W. and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl Acad. Sci. USA, 91, 1998-2002.
33. Prives, C. (1994) How loops, β sheets, and a helices help us to understand p53. Cell, 78, 543-546.
34. Purdie, C.A., Harrison, D.J., Peter, A., Dobbie, L., White, S., Howie, S.E.M., Salter, D.M., Bird, C.C., Wyllie, A.H., Hooper, M.L. and Clarke, A.R. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9, 603-609.
35. Sabbatini, P., Lin, J., Levine, A.J. and White, E. (1995) Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev., 9, 2184-2192.
36. Smith, M.L., Chen, I.-T. Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T.M., Kastan, M.B., O'Connor, P.M. and Fornace, A.J., Jr (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266, 1376-1380.
37. Stenger, J.E., Tegtmeyer, P., Mayr, G.A., Reed, M., Wang, Y., Wang, P., Hough, P.V.C. and Mastrangelo, I.A. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J., 13, 6011-6020.
38. Subler, M.A., Martin, D.W. and Deb, S. (1994) Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions. Oncogene, 9, 1351-1359.
39. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Ikawa, Y. and Aizawa, S. (1994) Enhanced cell proliferative potential in culture of cells from p53-deficient mice. Oncogene, 9, 603-609.
40. Wagner, A.J., Kokontis, J.M. and Hay, N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 WAF1/CIP1. Genes Dev., 8, 2817-2830.
41. Waldman, T., Kinzler, K.W. and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55, 5187-5190.
42. Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.-M., Wang, Z., Friedberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H.J., Forrester, K. and Harris, C.C. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet., 10, 188-195.
43. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Science, 366, 701-704.